Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and meaningful, especially for those of you who managed to survive the annual trek to the J.P. Morgan conference. Now that all the excitement is in the rear view mirror, the time has come to focus on the tasks ahead — meetings, deadlines, and the usual what-not. So please join us as we reach for a needed cup of stimulation and dig in for another busy day. Hope yours goes well and, of course, do keep in touch. We appreciate the tips and insights. …
Sen. Cory Booker (D-N.J.) is trying to overcome doubts that he is too close to the pharmaceutical industry ahead of an expected presidential campaign, The Hill says. The progressive criticism reached a crescendo in early 2017 when he voted against a budget amendment calling for importing drugs from abroad. But last week, Booker attempted to show he is tough on drug companies, appearing alongside Sen. Bernie Sanders (I-Vt.), a potential presidential rival, at a press conference on lowering drug prices.
About the Author Reprints
